These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11679179)

  • 1. Cyclin D1, p16 and retinoblastoma gene product expression as a predictor for prognosis in non-small cell lung cancer at stages I and II.
    Jin M; Inoue S; Umemura T; Moriya J; Arakawa M; Nagashima K; Kato H
    Lung Cancer; 2001 Nov; 34(2):207-18. PubMed ID: 11679179
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the RB pathway and cell-proliferative activity in non-small-cell lung cancers.
    Tanaka H; Fujii Y; Hirabayashi H; Miyoshi S; Sakaguchi M; Yoon HE; Matsuda H
    Int J Cancer; 1998 Apr; 79(2):111-5. PubMed ID: 9583722
    [TBL] [Abstract][Full Text] [Related]  

  • 3. G1 control gene status is frequently altered in resectable non-small cell lung cancer.
    Betticher DC; White GR; Vonlanthen S; Liu X; Kappeler A; Altermatt HJ; Thatcher N; Heighway J
    Int J Cancer; 1997 Oct; 74(5):556-62. PubMed ID: 9355981
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of p16 and/or pRb protein expression in NSCLC. An immunohistochemical and prognostic study.
    Chen JT; Chen YC; Chen CY; Wang YC
    Lung Cancer; 2001; 31(2-3):163-70. PubMed ID: 11165395
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormal expression of pRb, p16, and cyclin D1 in gastric adenocarcinoma and its lymph node metastases: relationship with pathological features and survival.
    Feakins RM; Nickols CD; Bidd H; Walton SJ
    Hum Pathol; 2003 Dec; 34(12):1276-82. PubMed ID: 14691913
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Alterations of expression of Rb, p16(INK4A) and cyclin D1 in non-small cell lung carcinoma and their clinical significance.
    Brambilla E; Moro D; Gazzeri S; Brambilla C
    J Pathol; 1999 Aug; 188(4):351-60. PubMed ID: 10440744
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The p16-cyclin D1/CDK4-pRb pathway and clinical outcome in epithelial ovarian cancer.
    Kusume T; Tsuda H; Kawabata M; Inoue T; Umesaki N; Suzuki T; Yamamoto K
    Clin Cancer Res; 1999 Dec; 5(12):4152-7. PubMed ID: 10632354
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclin D1 expression in non-small-cell lung cancers: its association with altered p53 expression, cell proliferation and clinical outcome.
    Mishina T; Dosaka-Akita H; Kinoshita I; Hommura F; Morikawa T; Katoh H; Kawakami Y
    Br J Cancer; 1999 Jun; 80(8):1289-95. PubMed ID: 10376986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes in expression of pRb, p16 and cyclin D1 in non-small cell lung cancer: an immunohistochemical study.
    Malusecka E; Zborek A; Krzyzowska-Gruca S
    Folia Histochem Cytobiol; 1999; 37(1):19-24. PubMed ID: 10091946
    [TBL] [Abstract][Full Text] [Related]  

  • 10. RB growth control evasion in lung cancer.
    Caputi M; Esposito V; Groger AM; De Luca A; Pacilio C; Dekan G; Giordano GG; Baldi F; Wolner E; Giordano A
    Anticancer Res; 1998; 18(4A):2371-4. PubMed ID: 9703881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cyclin D1, retinoblastoma gene protein, and p16 MTS1 protein in atypical adenomatous hyperplasia and adenocarcinoma of the lung. An immunohistochemical analysis.
    Kurasono Y; Ito T; Kameda Y; Nakamura N; Kitamura H
    Virchows Arch; 1998 Mar; 432(3):207-15. PubMed ID: 9531999
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic implications of cell cycle-related proteins in primary resectable pathologic N2 nonsmall cell lung cancer.
    Mohamed S; Yasufuku K; Hiroshima K; Nakajima T; Yoshida S; Suzuki M; Sekine Y; Shibuya K; Iizasa T; Farouk A; Fujisawa T
    Cancer; 2007 Jun; 109(12):2506-14. PubMed ID: 17487846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prognostic significance of cyclin D1 and retinoblastoma expression in combination with p53 abnormalities in primary, resected non-small cell lung cancers.
    Nishio M; Koshikawa T; Yatabe Y; Kuroishi T; Suyama M; Nagatake M; Sugiura T; Ariyoshi Y; Mitsudomi T; Takahashi T
    Clin Cancer Res; 1997 Jul; 3(7):1051-8. PubMed ID: 9815783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of retinoblastoma gene product in respiratory epithelium and sinonasal neoplasms: relationship with p16 and cyclin D1 expression.
    Schwerer MJ; Sailer A; Kraft K; Baczako K; Maier H
    Histol Histopathol; 2003 Jan; 18(1):143-51. PubMed ID: 12507294
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prognostic significance of p27KIP1 expression in resected non-small cell lung cancers: analysis in combination with expressions of p16INK4A, pRB, and p53.
    Hirabayashi H; Ohta M; Tanaka H; Sakaguchi M; Fujii Y; Miyoshi S; Matsuda H
    J Surg Oncol; 2002 Dec; 81(4):177-84; discussion 184. PubMed ID: 12451621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concomitant analysis of p16/INK4, cyclin D1, and retinoblastoma protein expression in esophageal squamous cell carcinoma.
    Nakamura T; Ide H; Eguchi R; Hayashi K; Takasaki K
    Hepatogastroenterology; 2003; 50(53):1321-6. PubMed ID: 14571727
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alterations of cell cycle regulators are less frequent in advanced non-small cell lung cancer than in resectable tumours.
    Gugger M; Kappeler A; Vonlanthen S; Altermatt HJ; Ris HB; Lardinois D; Borner MM; Heighway J; Betticher DC
    Lung Cancer; 2001; 33(2-3):229-39. PubMed ID: 11551418
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Altered expression of cell cycle regulators Cyclin D1, p14, p16, CDK4 and Rb in nodular melanomas.
    Bachmann IM; Straume O; Akslen LA
    Int J Oncol; 2004 Dec; 25(6):1559-65. PubMed ID: 15547691
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [The significance of p16, cyclin D1 and pRb expression in soft tissue leiomyosarcoma].
    Xu J; Yang G; Bu H; Guo L; Zhang S; Yang X
    Zhonghua Bing Li Xue Za Zhi; 1999 Dec; 28(6):414-7. PubMed ID: 11869553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced expression of cyclin D2 is associated with poor recurrence-free survival independent of cyclin D1 in stage III non-small cell lung cancer.
    Ko E; Kim Y; Park SE; Cho EY; Han J; Shim YM; Park J; Kim DH
    Lung Cancer; 2012 Aug; 77(2):401-6. PubMed ID: 22534667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.